Biomarkers for Diabetes

"Biomarker", are designated "molecular marker" or a "signature particle". These markers gives the degree of illness as they lay outside calmly. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular sicknesses. Biomarkers empower preventive measures to be connected at the subclinical stage and the reactions to preventive or helpful measures to be observed. Cases in the course of recent decades have yielded test sets, for the most part blood products and urine from an expansive classification of patients with both type 1 and type 2 diabetes.

  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

March 17-18, 2021

30th European Diabetes Congress

Barcelona, Spain
March 22-23, 2021

Global summit on Diabetes and Endocrinology

London, UK
April 13-14, 2021

World congress on Endocrinology and Metabolic syndrome

Auckland, Newzealand
May 10-11, 2021

30th World Diabetes & Heart Congress

Singapore, Singapore
June 16-17, 2021

World Summit on Diabetes

Rome, Italy
June 23-24, 2021

Virtual event on Obesity and Hormones

Rome, Italy
September 02-03, 2021

5th Annual Congress on Diabetes, Obesity and Its Complications

Vienna, Australia
October 14-15, 2021

Global congress on Endocrinology and Gynecology

Sydney, Australia
October 18-19, 2021

2nd Annual Summit on Diabetes and Endocrinology

Paris, France
November 16-17, 2021

World congress and Expo on Diabetes

Osaka, Japan
November 16-17, 2021

World congress and Expo on Diabetes

Osaka, Japan
December 07-08, 2021

13th World Congress on Endocrinology and Metabolic Disorders

Auckland, Newzealand

Biomarkers for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in